Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 784870004

Production
add
784870004
The component that hold information about this concept.
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)
Physostigmine salicylate 2.5 mg/ml and pilocarpine hydrochloride 20 mg/ml eye solution
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)

SCTID: 784870004, Defined, Active


784870004|Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)|
  • en Physostigmine salicylate 2.5 mg/ml and pilocarpine hydrochloride 20 mg/ml eye solution
  • en Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)

784870004 |Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)|

=== 422060001 |Conventional release eye solution (dose form)| +
    786272003 |Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 387035001 |Pilocarpine hydrochloride (substance)|,
          733722007 |Has concentration strength denominator unit (attribute)| = 258773002 |Milliliter (qualifier value)|,
          733725009 |Has concentration strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)|,
          762949000 |Has precise active ingredient (attribute)| = 387035001 |Pilocarpine hydrochloride (substance)| }
        { 732943007 |Has basis of strength substance (attribute)| = 69050006 |Physostigmine salicylate (substance)|,
          733722007 |Has concentration strength denominator unit (attribute)| = 258773002 |Milliliter (qualifier value)|,
          733725009 |Has concentration strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)|,
          762949000 |Has precise active ingredient (attribute)| = 69050006 |Physostigmine salicylate (substance)| }
Active

3765647017 - Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution (en) View

3765647017
en
Synonym (core metadata concept)
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution
900000000000020002 |Only initial character case insensitive (core metadata concept)|
Preferred
True

3765648010 - Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) (en) View

3765648010
en
Fully specified name (core metadata concept)
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

Relationship (11401650029) - 784870004 -> 773832000 (766939001) View

766939001 |Plays role (attribute)|
773832000 |Antiglaucoma therapeutic role (role)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401651025) - 784870004 -> 19338005 (766952006) View

766952006 |Count of base of active ingredient (attribute)|
19338005 |2 (qualifier value)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401652021) - 784870004 -> 38112003 (733723002) View

733723002 |Has concentration strength denominator value (attribute)|
38112003 |1 (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401656024) - 784870004 -> 732587006 (733724008) View

733724008 |Has concentration strength numerator value (attribute)|
732587006 |20 (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401665028) - 784870004 -> 732576003 (733724008) View

733724008 |Has concentration strength numerator value (attribute)|
732576003 |2.5 (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401667020) - 784870004 -> 38112003 (733723002) View

733723002 |Has concentration strength denominator value (attribute)|
38112003 |1 (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (11401655023) - 784870004 -> 258773002 (733722007) View

733722007 |Has concentration strength denominator unit (attribute)|
258773002 |Milliliter (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401657026) - 784870004 -> 69050006 (732943007) View

732943007 |Has basis of strength substance (attribute)|
69050006 |Physostigmine salicylate (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401658020) - 784870004 -> 258684004 (733725009) View

733725009 |Has concentration strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401660022) - 784870004 -> 422060001 (411116001) View

411116001 |Has dose form (attribute)|
422060001 |Conventional release eye solution (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401661021) - 784870004 -> 387035001 (762949000) View

762949000 |Has precise active ingredient (attribute)|
387035001 |Pilocarpine hydrochloride (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401662025) - 784870004 -> 258773002 (733722007) View

733722007 |Has concentration strength denominator unit (attribute)|
258773002 |Milliliter (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401663024) - 784870004 -> 258684004 (733725009) View

733725009 |Has concentration strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401664029) - 784870004 -> 69050006 (762949000) View

762949000 |Has precise active ingredient (attribute)|
69050006 |Physostigmine salicylate (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11401666027) - 784870004 -> 387035001 (732943007) View

732943007 |Has basis of strength substance (attribute)|
387035001 |Pilocarpine hydrochloride (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (11471910024) - 784870004 -> 786272003 (116680003) View

116680003 |Is a (attribute)|
786272003 |Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

786272003 View

786272003
Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form)
Physostigmine and pilocarpine only product in ocular dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

422060001 View

422060001
Conventional release eye solution (dose form)
Eye solution
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True
esc